Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/02/2012EP2445349A1 Compounds and methods for treating influenza
05/02/2012EP2445345A1 Benzamide derivatives
05/02/2012EP2445344A1 Method for treating a patient in need of aspirin therapy
05/02/2012EP2445340A1 Substituted hydroxamic acids and uses thereof
05/02/2012EP2445339A1 Diffusion enhancing compounds and their use alone or with thrombolytics
05/02/2012EP2445338A1 Synergistic combination to enhance blood glucose and insulin metabolism
05/02/2012EP2242482B1 Anti - retroviral combination
05/02/2012EP2238130B1 Carboxamide compounds and their use as calpain inhibitors
05/02/2012EP2217593B1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor
05/02/2012EP2142518B1 3,4-dihydroquinazoline derivatives
05/02/2012EP2136803B1 Triazole derivatives which are smo antagonists
05/02/2012EP2132175B1 Process for the preparation of loperamide
05/02/2012EP2124977B9 Method for treating or preventing systemic inflammation
05/02/2012EP2102161B1 Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl- 2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide
05/02/2012EP2086981B1 Compounds for inhibiting mitotic progression
05/02/2012EP2081926B1 Preparation and purification of mupirocin calcium
05/02/2012EP2058010B1 Pharmaceutical composition
05/02/2012EP2054165B9 Method of covering self-assembled metal or inorganic surfaces with gem-bisphosphonic compounds and uses thereof
05/02/2012EP2040548B1 Method for the treatment of neurological disorders by enhancing the activity of beta -glucocerebrosidase
05/02/2012EP2039687B1 Therapeutic or prophylactic agent for multiple sclerosis
05/02/2012EP2026832B1 Combination of interferon-beta and a cladribine regimen for treating multiple sclerosis
05/02/2012EP2007724B1 Piperidine derivatives for treatment of alzheimer's disease
05/02/2012EP1992361B1 Remedy or preventive for digestive ulcer
05/02/2012EP1955697B1 2-aminobenzamide derivatives as vanilloid receptor 1 (vr1) inhibitors useful for the treatment of pain or bladder function disorder
05/02/2012EP1945224B1 Reduction of side effects from aromatase inhibitors used for treating breast cancer
05/02/2012EP1945217B1 Combinations comprising a vegf receptor inhibitor and a penetration enhancer
05/02/2012EP1934177B1 Prolinamide derivatives as sodium channel modulators
05/02/2012EP1931201B1 Use of seh inhibitors as analgesics
05/02/2012EP1926726B1 Non-fluorescent chlorophyll catabolites
05/02/2012EP1912932B1 Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators
05/02/2012EP1901735B1 Polyphenol type compounds for the manufacture of a composition for preventing or treating diseases involving abnormal cell proliferation
05/02/2012EP1901715B1 Spray-drying process for producing a dry carnitine powder or granulate
05/02/2012EP1861403B1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
05/02/2012EP1860114B1 Nitroguanosine-3 ,5 -cyclic monophosphate and protein kinase g activator
05/02/2012EP1848275B1 Kappa opioid receptor ligands
05/02/2012EP1829545B1 Prostaglandin f2 alpha derivative containing products
05/02/2012EP1789042B1 1-alkoxy 1h-imidazo ring systems and methods
05/02/2012EP1785415B1 Piperidine derivative or pharmaceutically acceptable salt thereof
05/02/2012EP1756120B1 Purine derivative
05/02/2012EP1733720B1 Composition comprising reduced-form coenzyme q10 and carotenoid compound
05/02/2012EP1730152B1 Tetrahydroquinoline derivatives and a process for preparing the same
05/02/2012EP1724262B1 1-(2h)-isoquinolone derivative
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1702064B1 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
05/02/2012EP1693060B1 Therapeutic or preventive agents for ischemic neuropathy
05/02/2012EP1651616B1 Pyridazine derivatives and their use as therapeutic agents
05/02/2012EP1651605B1 Pyridyl derivatives and their use as therapeutic agents
05/02/2012EP1647546B1 Novel heteroaryl derivative
05/02/2012EP1634951B1 Novel protein
05/02/2012EP1627869B1 Vanilloid receptor modulators
05/02/2012EP1549246B1 Antibiotic micropheres for treatment of infections and osteomyelitis
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/02/2012EP1492511B3 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
05/02/2012EP1487431B1 Preventing and/or treating cardiovascular disease and/or associated heart failure
05/02/2012EP1429723B1 Treating effects of excessive reactive oxygen species
05/02/2012EP1418893B1 Compositions and techniques for localized therapy of restenosis
05/02/2012EP1415992B1 Diamine derivatives
05/02/2012EP1399158B1 Non-therapeutic method of suppressing oestrus in mammalian non-human animal
05/02/2012EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
05/02/2012EP1385595B1 Processes for preparing a cannabinoid-rich extract from cannabis plant material
05/02/2012EP1372682B1 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders
05/02/2012EP1256348B1 Remedies for hepatitis c
05/02/2012EP1160252B1 Avermectin derivatives
05/02/2012EP1032403B1 Nutritional supplement for cerebral metabolic insufficiencies
05/02/2012CN202207316U Apparatus for treating heart meridian tissue diseases through traditional Chinese medicine
05/02/2012CN1944454B Anti-cancer compound, method for extracting said compound, composition containing said compound, and its use in medicine production
05/02/2012CN1839139B Proteasome inhibitors and methods of using the same
05/02/2012CN102439453A Mitochondrial activity inhibitors of cancer-initiating cells and use thereof
05/02/2012CN102439150A Kanamycin antisense nucleic acid for the treatment of cancer
05/02/2012CN102439048A Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
05/02/2012CN102439026A Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin
05/02/2012CN102439024A Uracyl spirooxetane nucleosides
05/02/2012CN102439022A Novel sodium channel blocking compounds tetrodotoxin galactopyranosides
05/02/2012CN102439021A Novel galactoside inhibitors of galectins
05/02/2012CN102439018A Fosfluconazole derivatives, synthesis, and use in long acting formulations
05/02/2012CN102439015A 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/02/2012CN102439012A Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
05/02/2012CN102439011A Toll-like receptor modulators and treatment of diseases
05/02/2012CN102439010A Process for the production of fused, tricyclic sulfonamides
05/02/2012CN102439009A 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/02/2012CN102439008A 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
05/02/2012CN102439007A Amide derivative
05/02/2012CN102439006A Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
05/02/2012CN102439005A Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
05/02/2012CN102439003A Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
05/02/2012CN102439000A Benzamide and naphthamide derivatives inhibiting nuclear factor- kap pa (b) - (nf-kb)
05/02/2012CN102438998A Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
05/02/2012CN102438992A Method of inducing cleavage of amyloid precursor protein to form a novel fragment
05/02/2012CN102438991A Carbinol compound having heterocyclic linker
05/02/2012CN102438990A Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
05/02/2012CN102438989A Novel oxazolone and pyrrolidinone-substituted arylamides
05/02/2012CN102438988A Resorcinol derivatives as hsp90 inhibitors
05/02/2012CN102438986A Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
05/02/2012CN102438985A Substituted piperidines as par-1 antagonists
05/02/2012CN102438983A Compounds for treating inflammation and pain
05/02/2012CN102438981A Synthesis of 1-amino-1,3,3,5,5-pentamethylcyclohexane mesylate
05/02/2012CN102438979A New crystals of a benzoylbenzeneacetamide derivative
05/02/2012CN102438975A Substituted aromatic compounds and pharmaceutical uses thereof
05/02/2012CN102438645A Therapeutic modulation of vaginal epithelium boundary lubrication
1 ... 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 ... 7860